Transport of 7-Ethyl-10-hydroxycamptothecin (SN-38) by Breast Cancer Resistance Protein ABCG2 in Human Lung Cancer Cells
- 9 November 2001
- journal article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 288 (4), 827-832
- https://doi.org/10.1006/bbrc.2001.5850
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Breast Cancer Resistance Protein Directly Confers SN-38 Resistance of Lung Cancer CellsBiochemical and Biophysical Research Communications, 2001
- Irinotecan combined with fluorouracil compared with fluorouracil alone as first-line treatment for metastatic colorectal cancer: a multicentre randomised trialThe Lancet, 2000
- An inventory of the human ABC proteinsBiochimica et Biophysica Acta (BBA) - Biomembranes, 1999
- A multidrug resistance transporter from human MCF-7 breast cancer cellsProceedings of the National Academy of Sciences, 1998
- The Role of Glucuronidation in 7‐Ethyl‐10‐hydroxycamptothecin Resistance in vitroJapanese Journal of Cancer Research, 1997
- Human Canalicular Multispecific Organic Anion Transporter (cMOAT) Is Expressed in Human Lung, Gastric, and Colorectal Cancer CellsBiochemical and Biophysical Research Communications, 1997
- DX-8951F, a water-soluble camptothecin analog, exhibits potent antitumor activity against a human lung cancer cell line and its SN-38-resistant variantInternational Journal of Cancer, 1997
- ABC Transporters: From Microorganisms to ManAnnual Review of Cell Biology, 1992
- Structural and functional polarity of canalicular and basolateral plasma membrane vesicles isolated in high yield from rat liver.The Journal of cell biology, 1984
- Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4Nature, 1970